Related Experiment Videos
[The practice guideline 'Blood transfusion' (third integral revision)].
1Kwaliteitsinstituut voor de Gezondheidszorg CBO, Postbus 20.064, 3502 LB Utrecht. mwr@cbo.nl
Nederlands Tijdschrift Voor Geneeskunde
|December 17, 2005
Summary
This guideline details the hospital transfusion chain, emphasizing patient monitoring for reactions. It provides criteria for blood and platelet transfusions, and strategies like epoetin to reduce transfusion needs.
Area of Science:
- Hematology
- Transfusion Medicine
Background:
- The updated 'Blood transfusion' guideline comprehensively addresses the entire transfusion chain within hospitals.
- Pre-transfusion compatibility testing, including blood group typing and antibody screening, is crucial but does not eliminate transfusion reactions.
Discussion:
- Intensive patient monitoring for the initial 5-10 minutes of a transfusion is vital for timely recognition of adverse reactions.
- Transfusion decisions for patients with Hb levels of 4-6 mmol/l should consider individual patient characteristics.
- Thrombocyte transfusion is not recommended for thrombopenia caused by increased breakdown or pooling.
Key Insights:
- For thrombopenia due to leukemia, tumor infiltration, or drug toxicity, platelet counts of 10 x 10(9)/l or 20 x 10(9)/l should guide transfusion.
- Epoetin administration in renal insufficiency can avoid transfusions in over 70% of patients.
- Autotransfusion during surgery with significant blood loss reduces the need for allogeneic blood transfusions.
Outlook:
- Further research into optimizing transfusion triggers and exploring novel strategies for blood conservation is warranted.
- Implementation of comprehensive transfusion guidelines can improve patient safety and resource utilization.